Eris Lifesciences (BOM:540596) Accounts Payable : ₹0 Mil (As of Dec. 2023)

View and export this data going back to 2017. Start your Free Trial

What is Eris Lifesciences Accounts Payable?

Eris Lifesciences's Accounts Payable for the quarter that ended in Dec. 2023 was ₹0 Mil.

Eris Lifesciences's quarterly Accounts Payable increased from Jun. 2023 (₹0 Mil) to Sep. 2023 (₹1,505 Mil) but then declined from Sep. 2023 (₹1,505 Mil) to Dec. 2023 (₹0 Mil).

Eris Lifesciences's annual Accounts Payable increased from Mar. 2021 (₹1,026 Mil) to Mar. 2022 (₹1,178 Mil) and increased from Mar. 2022 (₹1,178 Mil) to Mar. 2023 (₹1,248 Mil).

Eris Lifesciences Accounts Payable Historical Data

The historical data trend for Eris Lifesciences's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Eris Lifesciences Accounts Payable Chart

Eris Lifesciences Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Accounts Payable

Get a 7-Day Free Trial

841.25

1,000.51

1,026.16

1,177.74

1,247.69

Eris Lifesciences Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Accounts Payable	Get a 7-Day Free Trial															-	1,247.69	-	1,505.25	-

Eris Lifesciences Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Eris Lifesciences Accounts Payable Related Terms

Thank you for viewing the detailed overview of Eris Lifesciences's Accounts Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Eris Lifesciences (BOM:540596) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Eris Lifesciences Ltd (BOM:540596) » Definitions » Accounts Payable

Traded in Other Exchanges

ERIS:India

Address

Ramdas Road, Plot No. 142/2, Shivarth Ambit, Off SBR, Near Swati Bungalows, Bodakdev, Ahmedabad, GJ, IND, 380054

Website

https://www.eris.co.in

Eris Lifesciences Ltd is an India-based company engaged in the manufacturing and sale of branded pharmaceutical formulations. It focuses on Lifestyle therapies such as Diabetes Care, Cardiac Care, Nutrition, Central Nervous System, and others. The company operates in a single segment that is pharmaceuticals. Some of its brands include Glimisave, Cyblex, Eritel, Atorsave and Crevast.

Eris Lifesciences (BOM:540596) Headlines

No Headlines